Table 2
Open in new tab

Procedural details

VariablevHP-SDControlP
Number of patients5050
Number of PVs200200
Total number of isolated PVs200 (100)200 (100)0.999
FAAVI37 (74)38 (76)0.817
Total procedure time, min59 ± 13101 ± 38<0.0001
Total procedure time, min (PVI only)56 ± 1098 ± 35<0.0001
Total LA dwelling time, min41 ± 973 ± 33<0.0001
Total fluoroscopy time, min7 ± 312 ± 6<0.001
Total amount of contrast agent, mL50 ± 1354 ± 280.364
Total radiofrequency time, s352 ± 811657 ± 570<0.0001
Total number of applications88 ± 2083 ± 310.314
Mean application duration, s4 ± 019 ± 6<0.0001
Mean contact force, g15 ± 318 ± 30.212
Mean power/application, Watt90 ± 032 ± 4<0.0001
Total delivered power/lesion, Joule331 ± 111565 ± 212<0.001
Teso Temp. > 38.5°C, n18 (36)——
Teso Temp. > 38.5°C, n/patient0.6——
Max Teso, °C42 ± 2——
Cavotricuspid isthmus block, n13 (26)13 (26)0.999
Periprocedural complications
Severe adverse events1 (2)3 (6)0.307
ȃCardiac tamponade01 (2)0.787
ȃSevere bleeding1 (2)2 (4)0.558
ȃPhrenic nerve injury000.999
ȃStroke or TIA000.999
Minor complications3 (6)2 (4)0.553
ȃMinor bleeding2 (4)2 (4)0.553
ȃPericardial effusion1 (2)00.787
ȃTransient air embolism000.999
ȃClinical apparent oesophagus injury000.999
ȃCharring on catheter tip000.999
VariablevHP-SDControlP
Number of patients5050
Number of PVs200200
Total number of isolated PVs200 (100)200 (100)0.999
FAAVI37 (74)38 (76)0.817
Total procedure time, min59 ± 13101 ± 38<0.0001
Total procedure time, min (PVI only)56 ± 1098 ± 35<0.0001
Total LA dwelling time, min41 ± 973 ± 33<0.0001
Total fluoroscopy time, min7 ± 312 ± 6<0.001
Total amount of contrast agent, mL50 ± 1354 ± 280.364
Total radiofrequency time, s352 ± 811657 ± 570<0.0001
Total number of applications88 ± 2083 ± 310.314
Mean application duration, s4 ± 019 ± 6<0.0001
Mean contact force, g15 ± 318 ± 30.212
Mean power/application, Watt90 ± 032 ± 4<0.0001
Total delivered power/lesion, Joule331 ± 111565 ± 212<0.001
Teso Temp. > 38.5°C, n18 (36)——
Teso Temp. > 38.5°C, n/patient0.6——
Max Teso, °C42 ± 2——
Cavotricuspid isthmus block, n13 (26)13 (26)0.999
Periprocedural complications
Severe adverse events1 (2)3 (6)0.307
ȃCardiac tamponade01 (2)0.787
ȃSevere bleeding1 (2)2 (4)0.558
ȃPhrenic nerve injury000.999
ȃStroke or TIA000.999
Minor complications3 (6)2 (4)0.553
ȃMinor bleeding2 (4)2 (4)0.553
ȃPericardial effusion1 (2)00.787
ȃTransient air embolism000.999
ȃClinical apparent oesophagus injury000.999
ȃCharring on catheter tip000.999

Values are counts, n (%) or mean (±SD).

PV(s), pulmonary vein(s); PVI, pulmonary vein isolation; FAAVI, first-attempt all veins isolated; LA, left atrium; min, minutes, s, seconds; g, grams.

Table 2
Open in new tab

Procedural details

VariablevHP-SDControlP
Number of patients5050
Number of PVs200200
Total number of isolated PVs200 (100)200 (100)0.999
FAAVI37 (74)38 (76)0.817
Total procedure time, min59 ± 13101 ± 38<0.0001
Total procedure time, min (PVI only)56 ± 1098 ± 35<0.0001
Total LA dwelling time, min41 ± 973 ± 33<0.0001
Total fluoroscopy time, min7 ± 312 ± 6<0.001
Total amount of contrast agent, mL50 ± 1354 ± 280.364
Total radiofrequency time, s352 ± 811657 ± 570<0.0001
Total number of applications88 ± 2083 ± 310.314
Mean application duration, s4 ± 019 ± 6<0.0001
Mean contact force, g15 ± 318 ± 30.212
Mean power/application, Watt90 ± 032 ± 4<0.0001
Total delivered power/lesion, Joule331 ± 111565 ± 212<0.001
Teso Temp. > 38.5°C, n18 (36)——
Teso Temp. > 38.5°C, n/patient0.6——
Max Teso, °C42 ± 2——
Cavotricuspid isthmus block, n13 (26)13 (26)0.999
Periprocedural complications
Severe adverse events1 (2)3 (6)0.307
ȃCardiac tamponade01 (2)0.787
ȃSevere bleeding1 (2)2 (4)0.558
ȃPhrenic nerve injury000.999
ȃStroke or TIA000.999
Minor complications3 (6)2 (4)0.553
ȃMinor bleeding2 (4)2 (4)0.553
ȃPericardial effusion1 (2)00.787
ȃTransient air embolism000.999
ȃClinical apparent oesophagus injury000.999
ȃCharring on catheter tip000.999
VariablevHP-SDControlP
Number of patients5050
Number of PVs200200
Total number of isolated PVs200 (100)200 (100)0.999
FAAVI37 (74)38 (76)0.817
Total procedure time, min59 ± 13101 ± 38<0.0001
Total procedure time, min (PVI only)56 ± 1098 ± 35<0.0001
Total LA dwelling time, min41 ± 973 ± 33<0.0001
Total fluoroscopy time, min7 ± 312 ± 6<0.001
Total amount of contrast agent, mL50 ± 1354 ± 280.364
Total radiofrequency time, s352 ± 811657 ± 570<0.0001
Total number of applications88 ± 2083 ± 310.314
Mean application duration, s4 ± 019 ± 6<0.0001
Mean contact force, g15 ± 318 ± 30.212
Mean power/application, Watt90 ± 032 ± 4<0.0001
Total delivered power/lesion, Joule331 ± 111565 ± 212<0.001
Teso Temp. > 38.5°C, n18 (36)——
Teso Temp. > 38.5°C, n/patient0.6——
Max Teso, °C42 ± 2——
Cavotricuspid isthmus block, n13 (26)13 (26)0.999
Periprocedural complications
Severe adverse events1 (2)3 (6)0.307
ȃCardiac tamponade01 (2)0.787
ȃSevere bleeding1 (2)2 (4)0.558
ȃPhrenic nerve injury000.999
ȃStroke or TIA000.999
Minor complications3 (6)2 (4)0.553
ȃMinor bleeding2 (4)2 (4)0.553
ȃPericardial effusion1 (2)00.787
ȃTransient air embolism000.999
ȃClinical apparent oesophagus injury000.999
ȃCharring on catheter tip000.999

Values are counts, n (%) or mean (±SD).

PV(s), pulmonary vein(s); PVI, pulmonary vein isolation; FAAVI, first-attempt all veins isolated; LA, left atrium; min, minutes, s, seconds; g, grams.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close